FTRE
Fortrea Holdings Inc.
Price Chart
Latest Quote
$16.26
+0.70 (+4.50%)
Current Price
| Previous Close | $15.56 |
| Open | $15.37 |
| Day High | $16.34 |
| Day Low | $15.25 |
| Volume | 528,690 |
Stock Information
| Shares Outstanding | 94.58M |
| Total Debt | $1.12B |
| Cash Equivalents | $147.50M |
| Revenue | $2.71B |
| Net Income | $-446.90M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.54B |
| EPS (TTM) | $-4.81 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.44B |
| Sales | $2.71B |
| Income | $-446.90M |
| Book/sh | $5.56 |
| Cash/sh | $1.56 |
| Employees | 14K |
Financial Ratios
| Quick Ratio | 0.83 |
| Current Ratio | 0.95 |
| Debt/Eq | 212.70 |
Returns & Margins
| ROA | -0.05% |
| ROE | -64.55% |
| Gross Margin | 18.86% |
| Operating Margin | 0.52% |
| Profit Margin | -16.50% |
Ownership
| Insider Ownership | 1.01% |
| Institutional Ownership | 110.42% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 15.10 |
| PEG | 0.34 |
| P/S | 0.57 |
| P/B | 2.92 |
Analyst Data
| Recommendation | none |
| Target Price | $16.21 |
Technical Indicators
| SMA20 | $15.77 |
| SMA50 | $13.68 |
| SMA200 | $12.50 |
| RSI | 55.81 |
| ATR | 1.0591 |
| Shares Float | 93.69M |
| Short Float | 11.79% |
| Short Ratio | 6.05 |
| Volatility | 2.11 |
| Rel Volume | 0.38 |
Performance History
| Week | -2.22% |
| Month | +23.74% |
| Quarter | +66.77% |
| 6 Months | -2.11% |
| YTD | -3.27% |
| Year | +205.64% |
| 10 Years | -45.98% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $16.26 | 528,690 |
| 2026-06-22 | $15.56 | 1,727,300 |
| 2026-06-18 | $15.31 | 3,008,100 |
| 2026-06-17 | $15.32 | 1,087,200 |
| 2026-06-16 | $15.98 | 1,472,700 |
| 2026-06-15 | $16.63 | 948,700 |
| 2026-06-12 | $16.48 | 964,700 |
| 2026-06-11 | $16.87 | 1,240,700 |
| 2026-06-10 | $16.34 | 1,051,900 |
| 2026-06-09 | $16.88 | 867,200 |
| 2026-06-08 | $16.57 | 1,186,800 |
| 2026-06-05 | $16.08 | 1,033,200 |
| 2026-06-04 | $17.25 | 2,990,500 |
| 2026-06-03 | $15.63 | 1,021,800 |
| 2026-06-02 | $15.36 | 1,372,400 |
| 2026-06-01 | $15.76 | 1,714,400 |
| 2026-05-29 | $15.39 | 2,042,400 |
| 2026-05-28 | $15.00 | 1,331,900 |
| 2026-05-27 | $13.42 | 944,300 |
| 2026-05-26 | $13.22 | 1,136,100 |
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
đ° Latest News
3 Cash-Producing Stocks with Warning Signs
StockStory âĸ 2026-06-17T09:16:51Z
3 Unpopular Stocks Weâre Skeptical Of
StockStory âĸ 2026-06-16T14:01:04Z
1 Unprofitable Stock to Research Further and 2 We Question
StockStory âĸ 2026-06-15T08:20:07Z
Assessing Fortrea Holdings (FTRE) Valuation After A Strong MultiâMonth Share Price Rally
Simply Wall St. âĸ 2026-06-10T02:12:52Z
3 Overrated Stocks We Approach with Caution
StockStory âĸ 2026-05-29T10:48:38Z
Spotting Winners: Fortrea (NASDAQ:FTRE) And Drug Development Inputs & Services Stocks In Q1
StockStory âĸ 2026-05-25T17:55:51Z
Fortreaâs Q1 Earnings Call: Our Top 5 Analyst Questions
StockStory âĸ 2026-05-15T13:32:55Z
Does Fortrea (FTRE) Shrinking Losses With Flat Sales Clarify Its Path to Sustainable Profitability?
Simply Wall St. âĸ 2026-05-06T20:18:56Z
Is Now An Opportune Moment To Examine Fortrea Holdings Inc. (NASDAQ:FTRE)?
Simply Wall St. âĸ 2026-05-06T10:22:38Z
Fortrea Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-05T18:34:50Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,219,600,000 | $2,160,600,000 | $2,243,200,000 | $2,104,500,000 |
| Cost Of Revenue | $2,219,600,000 | $2,162,200,000 | $2,251,900,000 | $2,112,600,000 |
| Total Revenue | $2,723,400,000 | $2,696,400,000 | $2,842,500,000 | $2,837,000,000 |
| Operating Revenue | $2,723,400,000 | $2,696,400,000 | $2,842,500,000 | $2,837,000,000 |
| Expenses | ||||
| Interest Expense | $91,400,000 | $123,800,000 | $69,700,000 | $200,000 |
| Total Expenses | $2,754,000,000 | $2,808,200,000 | $2,789,300,000 | $2,614,200,000 |
| Other Income Expense | $-861,000,000 | $-39,400,000 | $-14,000,000 | $-35,600,000 |
| Other Non Operating Income Expenses | $7,900,000 | $21,300,000 | $6,900,000 | $2,100,000 |
| Net Non Operating Interest Income Expense | $-91,400,000 | $-123,800,000 | $-69,700,000 | $-200,000 |
| Interest Expense Non Operating | $91,400,000 | $123,800,000 | $69,700,000 | $200,000 |
| Operating Expense | $534,400,000 | $646,000,000 | $537,400,000 | $501,600,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-986,200,000 | $-271,500,000 | $-31,700,000 | $145,900,000 |
| Net Interest Income | $-91,400,000 | $-123,800,000 | $-69,700,000 | $-200,000 |
| Normalized Income | $-299,769,000 | $-211,589,100 | $-15,189,000 | $175,306,000 |
| Net Income From Continuing And Discontinued Operation | $-986,200,000 | $-328,500,000 | $-25,200,000 | $186,200,000 |
| Total Operating Income As Reported | $-872,600,000 | $-161,900,000 | $32,000,000 | $187,100,000 |
| Net Income Common Stockholders | $-986,200,000 | $-328,500,000 | $-25,200,000 | $186,200,000 |
| Net Income | $-986,200,000 | $-328,500,000 | $-25,200,000 | $186,200,000 |
| Net Income Including Noncontrolling Interests | $-986,200,000 | $-328,500,000 | $-25,200,000 | $186,200,000 |
| Net Income Discontinuous Operations | $0 | $-57,000,000 | $6,500,000 | $40,300,000 |
| Net Income Continuous Operations | $-986,200,000 | $-271,500,000 | $-31,700,000 | $145,900,000 |
| Pretax Income | $-983,000,000 | $-275,000,000 | $-30,500,000 | $187,000,000 |
| Special Income Charges | $-842,000,000 | $-50,100,000 | $-21,200,000 | $-35,700,000 |
| Operating Income | $-30,600,000 | $-111,800,000 | $53,200,000 | $222,800,000 |
| Depreciation Amortization Depletion Income Statement | $78,000,000 | $85,300,000 | $89,300,000 | $85,500,000 |
| Depreciation And Amortization In Income Statement | $78,000,000 | $85,300,000 | $89,300,000 | $85,500,000 |
| Gross Profit | $503,800,000 | $534,200,000 | $590,600,000 | $724,400,000 |
| Per Share | ||||
| Diluted EPS | $-10.81 | $-3.67 | $-0.04 | $2.11 |
| Basic EPS | $-10.81 | $-3.67 | $-0.04 | $2.11 |
| Other | ||||
| Tax Effect Of Unusual Items | $-182,469,000 | $-789,100 | $-4,389,000 | $-8,294,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $55,300,000 | $-3,600,000 | $158,100,000 | $318,500,000 |
| Total Unusual Items | $-868,900,000 | $-60,700,000 | $-20,900,000 | $-37,700,000 |
| Total Unusual Items Excluding Goodwill | $-868,900,000 | $-60,700,000 | $-20,900,000 | $-37,700,000 |
| Reconciled Depreciation | $78,000,000 | $86,900,000 | $98,000,000 | $93,600,000 |
| EBITDA (Bullshit earnings) | $-813,600,000 | $-64,300,000 | $137,200,000 | $280,800,000 |
| EBIT | $-891,600,000 | $-151,200,000 | $39,200,000 | $187,200,000 |
| Diluted Average Shares | $91,230,342 | $89,509,537 | $85,000,000 | $88,400,000 |
| Basic Average Shares | $91,230,342 | $89,509,537 | $85,000,000 | $88,400,000 |
| Diluted NI Availto Com Stockholders | $-986,200,000 | $-328,500,000 | $-25,200,000 | $186,200,000 |
| Tax Provision | $3,200,000 | $-3,500,000 | $1,200,000 | $41,100,000 |
| Write Off | $3,200,000 | $4,800,000 | $0 | $2,000,000 |
| Impairment Of Capital Assets | $797,900,000 | $0 | $0 | $9,800,000 |
| Restructuring And Mergern Acquisition | $40,900,000 | $45,300,000 | $21,200,000 | $23,900,000 |
| Gain On Sale Of Security | $-26,900,000 | $-10,600,000 | $300,000 | $-2,000,000 |
| Selling General And Administration | $456,400,000 | $560,700,000 | $448,100,000 | $416,100,000 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,018,500,000 | $-1,003,700,000 | $-753,400,000 | $522,000,000 |
| Total Assets | $2,715,700,000 | $3,579,200,000 | $4,332,600,000 | $4,287,900,000 |
| Total Non Current Assets | $1,818,500,000 | $2,631,000,000 | $3,081,800,000 | $3,041,000,000 |
| Other Non Current Assets | $80,800,000 | $103,400,000 | $438,500,000 | $54,300,000 |
| Non Current Deferred Assets | $6,200,000 | $5,200,000 | $3,200,000 | $1,200,000 |
| Non Current Deferred Taxes Assets | $6,200,000 | $5,200,000 | $3,200,000 | $1,200,000 |
| Goodwill And Other Intangible Assets | $1,582,000,000 | $2,366,100,000 | $2,467,500,000 | $2,820,600,000 |
| Other Intangible Assets | $622,000,000 | $655,700,000 | $728,100,000 | $823,300,000 |
| Current Assets | $897,200,000 | $948,200,000 | $1,250,800,000 | $1,246,900,000 |
| Other Current Assets | $37,600,000 | $77,200,000 | $28,500,000 | $50,800,000 |
| Prepaid Assets | $65,000,000 | $58,500,000 | $34,100,000 | $32,700,000 |
| Receivables | $620,000,000 | $694,000,000 | $1,010,500,000 | $1,051,400,000 |
| Receivables Adjustments Allowances | $-41,200,000 | $-39,300,000 | $-31,700,000 | $-12,700,000 |
| Other Receivables | $517,300,000 | $542,300,000 | $600,000,000 | $585,700,000 |
| Taxes Receivable | $30,300,000 | $34,500,000 | $22,000,000 | $29,200,000 |
| Accounts Receivable | $113,600,000 | $156,500,000 | $420,200,000 | $449,200,000 |
| Cash Cash Equivalents And Short Term Investments | $174,600,000 | $118,500,000 | $108,600,000 | $112,000,000 |
| Cash And Cash Equivalents | $174,600,000 | $118,500,000 | $108,600,000 | $112,000,000 |
| Assets Held For Sale Current | - | $0 | $69,100,000 | - |
| Debt | ||||
| Net Debt | $878,200,000 | $1,006,000,000 | $1,483,400,000 | - |
| Total Debt | $1,116,000,000 | $1,198,500,000 | $1,672,000,000 | $63,400,000 |
| Long Term Debt And Capital Lease Obligation | $1,102,000,000 | $1,110,300,000 | $1,628,700,000 | $40,100,000 |
| Long Term Debt | $1,048,000,000 | $1,049,700,000 | $1,565,900,000 | - |
| Current Debt And Capital Lease Obligation | $14,000,000 | $88,200,000 | $43,300,000 | $23,300,000 |
| Current Debt | $4,800,000 | $74,800,000 | $26,100,000 | - |
| Other Current Borrowings | $4,800,000 | $74,800,000 | $26,100,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,152,200,000 | $2,216,800,000 | $2,618,500,000 | $945,300,000 |
| Total Non Current Liabilities Net Minority Interest | $1,238,900,000 | $1,267,300,000 | $1,840,100,000 | $246,300,000 |
| Other Non Current Liabilities | $39,300,000 | $35,300,000 | $32,100,000 | $21,700,000 |
| Non Current Deferred Liabilities | $97,600,000 | $121,700,000 | $147,700,000 | $184,500,000 |
| Non Current Deferred Taxes Liabilities | $97,600,000 | $121,700,000 | $147,700,000 | $184,500,000 |
| Current Liabilities | $913,300,000 | $949,500,000 | $778,400,000 | $699,000,000 |
| Other Current Liabilities | $28,200,000 | $39,000,000 | $78,100,000 | $27,100,000 |
| Current Deferred Liabilities | $473,800,000 | $353,300,000 | $214,200,000 | $271,500,000 |
| Payables And Accrued Expenses | $256,600,000 | $378,400,000 | $335,000,000 | $254,100,000 |
| Interest Payable | $18,000,000 | $23,300,000 | $22,500,000 | $0 |
| Payables | $88,700,000 | $190,900,000 | $192,900,000 | $121,000,000 |
| Total Tax Payable | $59,000,000 | $52,700,000 | $60,000,000 | $39,500,000 |
| Accounts Payable | $29,700,000 | $138,200,000 | $132,900,000 | $81,500,000 |
| Liabilities Heldfor Sale Non Current | - | $0 | $31,600,000 | - |
| Equity | ||||
| Common Stock Equity | $563,500,000 | $1,362,400,000 | $1,714,100,000 | $3,342,600,000 |
| Total Equity Gross Minority Interest | $563,500,000 | $1,362,400,000 | $1,714,100,000 | $3,342,600,000 |
| Stockholders Equity | $563,500,000 | $1,362,400,000 | $1,714,100,000 | $3,342,600,000 |
| Gains Losses Not Affecting Retained Earnings | $-170,000,000 | $-282,900,000 | $-215,500,000 | $-276,000,000 |
| Other Equity Adjustments | $-170,000,000 | $-282,900,000 | $-215,500,000 | $-276,000,000 |
| Retained Earnings | $-1,383,200,000 | $-397,000,000 | $-68,500,000 | $0 |
| Other Equity Interest | - | - | - | $3,618,600,000 |
| Other | ||||
| Ordinary Shares Number | $93,100,000 | $89,700,000 | $88,800,000 | $88,800,000 |
| Share Issued | $93,100,000 | $89,700,000 | $88,800,000 | $88,800,000 |
| Tangible Book Value | $-1,018,500,000 | $-1,003,700,000 | $-753,400,000 | $522,000,000 |
| Invested Capital | $1,616,300,000 | $2,486,900,000 | $3,306,100,000 | $3,342,600,000 |
| Working Capital | $-16,100,000 | $-1,300,000 | $472,400,000 | $547,900,000 |
| Capital Lease Obligations | $63,200,000 | $74,000,000 | $80,000,000 | $63,400,000 |
| Total Capitalization | $1,611,500,000 | $2,412,100,000 | $3,280,000,000 | $3,342,600,000 |
| Additional Paid In Capital | $2,116,600,000 | $2,042,200,000 | $1,998,000,000 | $0 |
| Capital Stock | $100,000 | $100,000 | $100,000 | $0 |
| Common Stock | $100,000 | $100,000 | $100,000 | $0 |
| Long Term Capital Lease Obligation | $54,000,000 | $60,600,000 | $62,800,000 | $40,100,000 |
| Current Deferred Revenue | $473,800,000 | $353,300,000 | $214,200,000 | $271,500,000 |
| Current Capital Lease Obligation | $9,200,000 | $13,400,000 | $17,200,000 | $23,300,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $140,700,000 | $90,600,000 | $107,800,000 | $123,000,000 |
| Current Accrued Expenses | $167,900,000 | $187,500,000 | $142,100,000 | $133,100,000 |
| Goodwill | $960,000,000 | $1,710,400,000 | $1,739,400,000 | $1,997,300,000 |
| Net PPE | $149,500,000 | $156,300,000 | $172,600,000 | $164,900,000 |
| Accumulated Depreciation | $-183,300,000 | $-164,100,000 | $-149,400,000 | $-128,700,000 |
| Gross PPE | $332,800,000 | $320,400,000 | $322,000,000 | $293,600,000 |
| Construction In Progress | $23,900,000 | $9,500,000 | $9,600,000 | $41,400,000 |
| Other Properties | $56,000,000 | $66,200,000 | $74,700,000 | $50,000,000 |
| Machinery Furniture Equipment | $171,500,000 | $162,500,000 | $159,900,000 | $157,600,000 |
| Land And Improvements | $81,400,000 | $82,200,000 | $77,800,000 | $14,600,000 |
| Properties | $0 | $0 | $0 | $0 |
| Leases | - | $82,200,000 | $77,800,000 | $30,000,000 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $88,300,000 | $237,300,000 | $128,100,000 | $28,300,000 |
| Operating Activities | ||||
| Operating Cash Flow | $113,500,000 | $262,800,000 | $168,400,000 | $82,700,000 |
| Cash Flow From Continuing Operating Activities | $113,500,000 | $262,800,000 | $168,400,000 | $82,700,000 |
| Operating Gains Losses | $36,400,000 | $100,000 | $4,400,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-25,200,000 | $-25,500,000 | $-40,300,000 | $-54,400,000 |
| Investing Cash Flow | $14,400,000 | $251,600,000 | $-31,800,000 | $-54,000,000 |
| Cash Flow From Continuing Investing Activities | $14,400,000 | $251,600,000 | $-31,800,000 | $-54,000,000 |
| Capital Expenditure Reported | $-25,200,000 | $-25,500,000 | $-40,300,000 | $-54,400,000 |
| Net Other Investing Changes | - | $500,000 | $8,500,000 | $400,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-76,300,000 | $-497,800,000 | $-140,800,000 | $-6,300,000 |
| Cash Flow From Continuing Financing Activities | $-76,300,000 | $-497,800,000 | $-140,800,000 | $-6,300,000 |
| Net Other Financing Charges | $-600,000 | $-15,100,000 | $-1,756,800,000 | $-6,300,000 |
| Other | ||||
| Repayment Of Debt | $-529,600,000 | $-1,309,200,000 | $-179,400,000 | $0 |
| Issuance Of Debt | $453,900,000 | $826,500,000 | $1,795,400,000 | $0 |
| End Cash Position | $174,600,000 | $118,500,000 | $108,600,000 | $110,400,000 |
| Beginning Cash Position | $118,500,000 | $108,600,000 | $110,400,000 | $94,600,000 |
| Effect Of Exchange Rate Changes | $4,500,000 | $-6,700,000 | $2,400,000 | $-6,600,000 |
| Changes In Cash | $51,600,000 | $16,600,000 | $-4,200,000 | $22,400,000 |
| Net Issuance Payments Of Debt | $-75,700,000 | $-482,700,000 | $1,616,000,000 | $0 |
| Net Long Term Debt Issuance | $-75,700,000 | $-482,700,000 | $1,616,000,000 | $0 |
| Long Term Debt Payments | $-529,600,000 | $-1,309,200,000 | $-179,400,000 | $0 |
| Long Term Debt Issuance | $453,900,000 | $826,500,000 | $1,795,400,000 | $0 |
| Net Business Purchase And Sale | $39,600,000 | $276,600,000 | $0 | $0 |
| Sale Of Business | $39,600,000 | $276,600,000 | $0 | $0 |
| Change In Working Capital | $114,700,000 | $384,000,000 | $22,500,000 | $-248,200,000 |
| Change In Other Working Capital | $114,800,000 | $140,000,000 | $-2,200,000 | $-30,100,000 |
| Change In Payables And Accrued Expense | $-103,400,000 | $12,200,000 | $81,500,000 | $-100,600,000 |
| Change In Accrued Expense | $6,500,000 | $5,000,000 | $26,200,000 | $-125,400,000 |
| Change In Payable | $-109,900,000 | $7,200,000 | $55,300,000 | $24,800,000 |
| Change In Account Payable | $-109,900,000 | $7,200,000 | $55,300,000 | $24,800,000 |
| Change In Prepaid Assets | $32,400,000 | $-78,100,000 | $-3,400,000 | $-9,100,000 |
| Change In Receivables | $70,900,000 | $309,900,000 | $-53,400,000 | $-108,400,000 |
| Other Non Cash Items | $16,000,000 | $23,300,000 | $26,400,000 | $29,000,000 |
| Stock Based Compensation | $74,400,000 | $58,400,000 | $42,700,000 | $25,400,000 |
| Provisionand Write Offof Assets | $12,000,000 | $22,200,000 | $27,800,000 | $3,400,000 |
| Asset Impairment Charge | $800,200,000 | $41,000,000 | $13,400,000 | $9,800,000 |
| Deferred Tax | $-32,000,000 | $-24,600,000 | $-41,600,000 | $-16,500,000 |
| Deferred Income Tax | $-32,000,000 | $-24,600,000 | $-41,600,000 | $-16,500,000 |
| Depreciation Amortization Depletion | $78,000,000 | $86,900,000 | $98,000,000 | $93,600,000 |
| Depreciation And Amortization | $78,000,000 | $86,900,000 | $98,000,000 | $93,600,000 |
| Net Foreign Currency Exchange Gain Loss | $36,400,000 | $-19,500,000 | $4,400,000 | - |
| Gain Loss On Sale Of Business | $0 | $19,600,000 | $0 | $0 |
| Net Income From Continuing Operations | $-986,200,000 | $-328,500,000 | $-25,200,000 | $186,200,000 |
| Net Short Term Debt Issuance | - | - | $0 | $0 |
| Short Term Debt Payments | - | - | $-164,000,000 | $0 |
| Short Term Debt Issuance | - | - | $164,000,000 | $0 |
| Amortization Cash Flow | - | - | $63,800,000 | $65,700,000 |
| Amortization Of Intangibles | - | - | $63,800,000 | $65,700,000 |
| Depreciation | - | - | $32,600,000 | $27,000,000 |
| Purchase Of Business | - | - | - | $0 |
Fetched: 2026-06-20